15-78727236-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000564933.6(GOLGA6GP):​n.60G>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.629 in 532,820 control chromosomes in the GnomAD database, including 111,394 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.58 ( 28277 hom., cov: 32)
Exomes 𝑓: 0.65 ( 83117 hom. )

Consequence

GOLGA6GP
ENST00000564933.6 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.667

Publications

29 publications found
Variant links:
Genes affected
GOLGA6GP (HGNC:55709): (golgin A6 family member G%2C pseudogene [Source:HGNC Symbol%3BAcc:HGNC:55709])
CHRNB4 (HGNC:1964): (cholinergic receptor nicotinic beta 4 subunit) This gene is found within a conserved gene cluster and encodes one of the beta subunits of the nicotinic acetylcholine receptor (nAChRs) superfamily which form ligand-gated ion channels with a central pore that forms a cation channel. Neuronal nAChRs are pentameric structures that can be either homomeric or heteromeric, with heteromeric structures containing both alpha and beta subunits. Each subunit contains an extracellular amino terminus and four transmembrane domains. Nicotine is one of the agonists that binds to the receptor. Variants in this gene have been associated with nicotine dependence and lung cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2017]
CHRNB4 Gene-Disease associations (from GenCC):
  • lung cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.746 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC105370913XR_932508.2 linkn.1347+332C>A intron_variant Intron 1 of 2
LOC105370913XR_932509.2 linkn.1303+376C>A intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GOLGA6GPENST00000564933.6 linkn.60G>T non_coding_transcript_exon_variant Exon 1 of 13 6
CHRNB4ENST00000558216.1 linkn.143+376C>A intron_variant Intron 1 of 2 2
ENSG00000290426ENST00000565476.5 linkn.373-1716G>T intron_variant Intron 3 of 4 4

Frequencies

GnomAD3 genomes
AF:
0.578
AC:
87697
AN:
151762
Hom.:
28277
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.281
Gnomad AMI
AF:
0.780
Gnomad AMR
AF:
0.601
Gnomad ASJ
AF:
0.670
Gnomad EAS
AF:
0.485
Gnomad SAS
AF:
0.538
Gnomad FIN
AF:
0.599
Gnomad MID
AF:
0.658
Gnomad NFE
AF:
0.751
Gnomad OTH
AF:
0.600
GnomAD4 exome
AF:
0.650
AC:
247543
AN:
380942
Hom.:
83117
Cov.:
2
AF XY:
0.649
AC XY:
140695
AN XY:
216896
show subpopulations
African (AFR)
AF:
0.285
AC:
2963
AN:
10408
American (AMR)
AF:
0.526
AC:
18823
AN:
35800
Ashkenazi Jewish (ASJ)
AF:
0.668
AC:
7766
AN:
11632
East Asian (EAS)
AF:
0.504
AC:
6668
AN:
13218
South Asian (SAS)
AF:
0.545
AC:
36734
AN:
67346
European-Finnish (FIN)
AF:
0.612
AC:
19679
AN:
32156
Middle Eastern (MID)
AF:
0.678
AC:
1369
AN:
2018
European-Non Finnish (NFE)
AF:
0.744
AC:
142646
AN:
191718
Other (OTH)
AF:
0.655
AC:
10895
AN:
16646
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
4235
8470
12704
16939
21174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.578
AC:
87711
AN:
151878
Hom.:
28277
Cov.:
32
AF XY:
0.572
AC XY:
42429
AN XY:
74206
show subpopulations
African (AFR)
AF:
0.281
AC:
11619
AN:
41400
American (AMR)
AF:
0.600
AC:
9172
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.670
AC:
2325
AN:
3470
East Asian (EAS)
AF:
0.485
AC:
2499
AN:
5150
South Asian (SAS)
AF:
0.539
AC:
2592
AN:
4812
European-Finnish (FIN)
AF:
0.599
AC:
6319
AN:
10542
Middle Eastern (MID)
AF:
0.653
AC:
192
AN:
294
European-Non Finnish (NFE)
AF:
0.751
AC:
51031
AN:
67916
Other (OTH)
AF:
0.593
AC:
1252
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1588
3175
4763
6350
7938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
710
1420
2130
2840
3550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.680
Hom.:
92947
Bravo
AF:
0.566
Asia WGS
AF:
0.457
AC:
1592
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.25
DANN
Benign
0.61
PhyloP100
-0.67

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs899997; hg19: chr15-79019578; COSMIC: COSV73739319; API